Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Hugo A. Tempelman"'
Autor:
Irtiza S. Tahir, Alinda G. Vos, Johanna A.A. Damen, Roos E. Barth, Hugo A. Tempelman, Diederick E. Grobbee, Karine Scheuermaier, Willem D.F. Venter, Kerstin Klipstein-Grobusch
Publikováno v:
Southern African Journal of HIV Medicine, Vol 23, Iss 1, Pp e1-e10 (2022)
Background: Current cardiovascular risk assessment in people living with HIV is based on general risk assessment tools; however, whether these tools can be applied in sub-Saharan African populations has been questioned. Objectives: The study aimed t
Externí odkaz:
https://doaj.org/article/c5ab32b0ac984f60a48cfafdf8eac941
Autor:
Alinda G. Vos, Roos E. Barth, Kerstin Klipstein‐Grobusch, Hugo A. Tempelman, Walter L. J. Devillé, Caitlin Dodd, Roel A. Coutinho, Diederick E. Grobbee
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 7 (2020)
Background HIV is associated with an increased risk of cardiovascular disease (CVD) in high‐income countries. Little is known about the CVD burden in sub‐Saharan Africa, where 70% of the world's HIV‐positive population lives. This study aims to
Externí odkaz:
https://doaj.org/article/e1128cae787d4f8ca04059c0e6b9b7ae
Publikováno v:
AIDS Research and Treatment, Vol 2011 (2011)
Objective. To define the long-term (2–4 years) clinical and virological outcome of an antiretroviral treatment (ART) programme in rural South Africa. Methods. We performed a retrospective observational cohort study, including 735 patients who initi
Externí odkaz:
https://doaj.org/article/39403560d6614f4db718301d40dd9c09
Autor:
Annemiek E. M. de Vries, Zanele Xaba, Sehulong R. Moraba, Luise Goerlitz, Hugo A. Tempelman, Kerstin Klipstein‐Grobusch, Lucas E. Hermans, Karine Scheuermaier, Walter L. J. M. Devillé, Alinda G. Vos
Publikováno v:
Tropical Medicine & International Health. 28:367-373
Autor:
Laura E. P. Huyveneers, Mathapelo Maphanga, Chijioke N. Umunnakwe, Larissa Bosman‐de Boer, Robert S. Moraba, Hugo A. Tempelman, Annemarie M. J. Wensing, Lucas E. Hermans
Publikováno v:
Tropical Medicine & International Health. 28:335-342
Autor:
Lucas E Hermans, Chijioke N Umunnakwe, Samanta T Lalla-Edward, Shane K Hebel, Hugo A Tempelman, Monique Nijhuis, Willem D F Venter, Annemarie M J Wensing
Publikováno v:
Clinical Infectious Diseases. 76:e553-e560
Background Viral rebound during antiretroviral treatment (ART) is most often driven by suboptimal adherence in the absence of drug resistance. We assessed the diagnostic performance of point-of-care (POC) tenofovir (TFV) detection in urine for the pr
Autor:
Lucas E, Hermans, Laura M, Hofstra, Rob, Schuurman, Rob, Ter Heine, David M, Burger, Stijn A J, Talboom, Dorien, De Jong, Hugo A, Tempelman, Willem D F, Venter, Monique, Nijhuis, Annemarie M J, Wensing
Publikováno v:
Aids, 36, 923-931
Aids, 36, 7, pp. 923-931
Aids, 36, 7, pp. 923-931
Pretreatment drug resistance (PDR) prevalence in sub-Saharan Africa is rising, but evidence of its impact on efavirenz (EFV)-based antiretroviral treatment (ART) is inconclusive. We determined the impact of PDR on outcomes of EFV-based ART in a suban
Autor:
Lucas E, Hermans, Chijioke N, Umunnakwe, Samanta T, Lalla-Edward, Shane K, Hebel, Hugo A, Tempelman, Monique, Nijhuis, Willem D F, Venter, Annemarie M J, Wensing
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Viral rebound during antiretroviral treatment (ART) is most often driven by suboptimal adherence in the absence of drug resistance. We assessed the diagnostic performance of point-of-care (POC) tenofovir (TFV) detection in urine for the prediction of
Autor:
Elise M Frijters, Hugo A. Tempelman, John de Wit, Walter L J M Devillé, Lucas E Hermans, Annemarie M. J. Wensing
Publikováno v:
AIDS. 34:1261-1288
Introduction Loss to follow-up (LTFU) rates from antiretroviral treatment (ART) programmes in low- and middle-income countries (LMIC) are high, leading to poor treatment outcomes and onward transmission of HIV. Knowledge of risk factors is required t
Autor:
Chijioke N. Umunnakwe, Zinhle N. Makatini, Mathapelo Maphanga, Anele Mdunyelwa, Khamusi M. Mlambo, Puseletso Manyaka, Monique Nijhuis, Annemarie Wensing, Hugo A. Tempelman
Publikováno v:
PloS one. 17(6)
The rapid emergence and spread of numerous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants across the globe underscores the crucial need for continuous SARS-CoV-2 surveillance to ensure that potentially more pathogenic variants